Table 3.
The tumor types and LM332 subunits recognized in patient sera among 52 anti-LM332-type MMP cases.
| Tumor (Number of Patients) |
LM332 Subunits, Positive Cases (%) | ||
|---|---|---|---|
| LMα3 | LMβ3 | LMγ2 | |
| Lung (17) | 10 (58.82%) | 4 (23.53%) | 7 (41.18%) |
| Gastric (13) | 7 (53.85%) | 4 (30.77%) | 3 (23.08%) |
| Uterine (10) | 4 (40.00%) | unknown | 2 (20.00%) |
| Pancreatic (6) | 3 (50.00%) | 3 (50.00%) | 4 (66.67%) |
| Colon (6) | 4 (66.67%) | unknown | unknown |
| Ovary (5) | unknown | unknown | 4 (80%) |
| Prostate (4) | 1 (25.00%) | 2 (50.00%) | 1 (25%) |
| Thyroid (4) | 1 (25.00%) | 0 (0.00%) | 4 (100.00%) |
| B-cell lymphoma (3) | 1 (33.33%) | unknown | 1 (33.33%) |
| Leukemia (3) | unknown | 2 (66.67%) | unknown |
| Liver (3) | 2 (66.67%) | 2 (66.67%) | 2 (67.67%) |
| kidney (3) | unknown | unknown | 2 (67.67%) |
| Adenocarcinoma (2) | 2 (100.00%) | 1 (50.00%) | 1 (50.00%) |
| Tongue (2) | 1 (50.00%) | 1 (50.00%) | 2 (100.00%) |
| Pharynx (1) | 1 (100.00%) | 1 (100.00%) | 1 (100.00%) |
| Breast (1) | 0 (0.00%) | 0 (0.00%) | 1 (100.00%) |
| Cutaneous lymphoma (1) | 1 (100.00%) | 0 (0.00%) | 0 (0.00%) |
| Total | 35 (67.31%) | 19 (36.54%) | 28 (53.85%) |